×
Correction: PDF
$ 0.00
Correction: PDF quantity
$ 0.00
×
Time Trends in Lifetime Incidence Rates of First-Time Diagnosed Bipolar and Depressive Disorders Across 16 Years in Danish Psychiatric Hospitals: A Nationwide Study PDF
$ 0.00
Time Trends in Lifetime Incidence Rates of First-Time Diagnosed Bipolar and Depressive Disorders Across 16 Years in Danish Psychiatric Hospitals: A Nationwide Study PDF quantity
$ 0.00
×
Drug Interactions Between Psychotropic Medications and Treatment of Mpox (tecovirimat and cidofovir) PDF
$ 0.00
Drug Interactions Between Psychotropic Medications and Treatment of Mpox (tecovirimat and cidofovir) PDF quantity
$ 0.00
×
Schizophrenia: The Role of Dopamine and Glutamate PDF
$ 0.00
Schizophrenia: The Role of Dopamine and Glutamate PDF quantity
$ 0.00
×
Childhood Stimulant Treatment and Risk for Later Substance Abuse PDF
$ 0.00
Childhood Stimulant Treatment and Risk for Later Substance Abuse PDF quantity
$ 0.00
×
New Developments in the Treatment of Alzheimer's Disease PDF
$ 0.00
New Developments in the Treatment of Alzheimer's Disease PDF quantity
$ 0.00
×
Happiness and Treatment Outcome in Resistant Depression PDF
$ 0.00
Happiness and Treatment Outcome in Resistant Depression PDF quantity
$ 0.00
×
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia PDF
$ 0.00
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia PDF quantity
$ 0.00
×
Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studies PDF
$ 0.00
Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studies PDF quantity
$ 0.00
×
Casting Light From the Shadows: Coping and Defenses Amidst a Pandemic PDF
$ 0.00
Casting Light From the Shadows: Coping and Defenses Amidst a Pandemic PDF quantity
$ 0.00
×
Gratitude in a Year of Adversity PDF
$ 0.00
Gratitude in a Year of Adversity PDF quantity
$ 0.00
×
Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized Controlled Trial PDF
$ 0.00
Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized Controlled Trial PDF quantity
$ 0.00
Coupon: Apply coupon
Update cart